Significance: The MedDiet participants had lower cellular and plasma concentrations of inflammatory markers related to atherosclerosis at 3 and 5 y.
This study tested the hypothesis that weight loss from calorie restriction and exercise combined (CREX) improves cardiovascular disease (CVD) risk factors more than similar weight loss from calorie restriction (CR) or endurance exercise training (EX) alone. Overweight, sedentary men and women (n=52; aged 45-65 y) were randomly assigned to undergo 6-8% weight loss by using CR, EX, or CREX. Outcomes were measured before and after weight loss and included maximal oxygen consumption (VO 2max ), resting blood pressure, fasting plasma lipids, glucose, CRP, and arterial stiffness. Reductions in body weight (∼7%) were similar in all groups. VO 2max changed in proportion to the amount of exercise performed (CR, −1% ± 3%; EX, +22% ± 3%; and CREX, +11% ± 3%). None of the changes in CVD risk factors differed between groups. For all groups combined, significant decreases were observed for systolic and diastolic blood pressure (−5 ± 1 and −4 ± 1 mm Hg, respectively); total cholesterol (−17 ± 4 mg/dL), non-HDL-cholesterol (−16 ± 3 mg/dL), triglycerides (−18 ± 8 mg/ dL), and glucose (−3 ± 1 mg/dL). These changes would be expected to decrease the lifetime risk of CVD from 46% to 36%.
Mediterranean Diet Score and Left Ventricular Structure and Function:
The Multi-Ethnic Study of Atherosclerosis E.B. Levitan, A. Ahmed, D.K. Arnett, J.F. Polak, W.G. Hundley, D.A. Bluemke, et al. American Journal of Clinical Nutrition, Vol. 104, No. 3; pp. 595-602 DOI: 10.3945/ajcn.115.128579 Link to full text: Click here Significance: A higher Mediterranean diet score was cross-sectionally associated with a higher left ventricular (LV) mass, which is balanced by a higher LV volume as well as a higher ejection fraction and stroke volume.
Cross-sectional associations of a diet-score assessment of a Mediterranean dietary pattern were examined with left ventricular (LV) mass, volume, mass-to-volume ratio, stroke volume, and ejection fraction. LV variables were measured with the use of cardiac MRI in 4497 participants in the MESA study who were 45-84 years of age and without clinical CVD. A Mediterranean diet score was calculated from intakes of fruit, vegetables, nuts, legumes, whole grains, fish, red meat, the monounsaturated fat:saturated fat ratio, and alcohol that were self-reported with the use of a food-frequency questionnaire. The Mediterranean diet score had a slight U-shaped association with LV mass (adjusted means: 146, 145, 146, and 147 g across quartiles of diet score, respectively; P-quadratic trend = 0.04). The score was linearly associated with LV volume, stroke volume, and ejection fraction: for each +1-U difference in score, LV volume was 0.4 mL higher (95% CI: 0.0, 0.8 mL higher), the stroke volume was 0.5 mL higher (95% CI: 0.2, 0.8 mL higher), and the ejection fraction was 0.2 percentage points higher (95% CI: 0.1, 0.3 percentage points higher). The score was not associated with the massto-volume ratio.
Inflammatory Markers
Associations Between Nut Consumption and Inflammatory Biomarkers Z. Yu, V.S. Malik, N. Keum, F.B. Hu, E.L. Giovannucci, M.J. Stampfer, et al. American Journal of Clinical Nutrition, Vol. 104, No. 3; pp. 722-728 DOI: 10.3945/ajcn.116.134205 Link to full text: Click here Significance: Frequent nut consumption was associated with a healthy profile of inflammatory biomarkers.
Habitual nut consumption in relation to inflammatory biomarkers was investigated in 2 large cohorts of US men and women. Cross-sectional data from 5013 participants in the Nurses' Health Study (NHS) and Health Professionals Follow-Up Study (HPFS) who were free of diabetes were investigated. Nut intake was estimated from food-frequency questionnaires, and cumulative averages from 1986 and 1990 in the NHS and from 1990 and 1994 in the HPFS were used. Plasma biomarkers were collected in 1989 -1990 in the NHS and 1993 -1995 in the HPFS. Multivariate linear regression was used to assess the associations of nut consumption with fasting plasma CRP (n=4941), IL-6 (n=2859), and tumor necrosis factor receptor 2 (TNFR2, n=2905). A greater intake of nuts was associated with lower amounts of a subset of inflammatory biomarkers, after adjusting for covariates. The relative concentrations (ratios) and 95% CIs comparing subjects with nut intake of ≥5 times/wk and those in the categories of never or almost never were as follows: CRP: 0.80 (0.69, 0.90), P-trend = 0.0003; and IL-6: 0.86 (0.77, 0.97), P-trend = 0.006. These associations remained significant after further adjustment for BMI. Substituting 3 servings of nuts/wk for 3 servings of red meat, processed meat, eggs, or refined grains/wk was associated with significantly lower CRP and IL-6. There is much emerging information surrounding the impact of sleep duration and quality on food choice and consumption in both children and adults. However, less attention has been paid to the effects of dietary patterns and specific foods on nighttime sleep. Early studies have shown that certain dietary patterns may affect not only daytime alertness but also nighttime sleep. This review describes the role of food consumption on sleep. Research has focused on the effects of mixed meal patterns, such as high-carbohydrate plus low-fat or low-carbohydrate diets, over the short term on sleep. Such studies highlight a potential effect of macronutrient intakes on sleep variables, particularly alterations in slow wave sleep and rapid eye movement sleep with changes in carbohydrate and fat intakes. Other studies examined the intake of specific foods (e.g., milk, fatty fish, tart cherry juice, and kiwifruit) consumed at a fixed time relative to sleep, on sleep architecture and quality. The relation between habitual anthocyanin and flavanone intake and coronary artery disease and stroke in the Health Professionals Follow-Up Study were examined. Healthy men (n=43,880) who had no prior diagnosed cardiovascular disease (CVD) or cancer were followed for 24 years and 4046 myocardial infarction (MI) and 1572 stroke cases were confirmed by medical records. Although higher anthocyanin intake was not associated with total or fatal MI risk, after multivariate adjustment an inverse association with nonfatal MI was observed (HR: 0.87; 95% CI: 0.75, 1.00; P = 0.04; P-trend = 0.098); this association was stronger in normotensive participants (HR: 0.81; 95% CI: 0.69, 0.96; P-interaction = 0.03). Anthocyanin intake was not associated with stroke risk. Although flavanone intake was not associated with MI or total stroke risk, higher intake was associated with a lower risk of ischemic stroke (HR: 0.78; 95% CI: 0.62, 0.97; P = 0.03, P-trend = 0.059), with the greatest magnitude in participants aged ≥65 y (P-interaction = 0.04). 5) with the lowest (quintile 1) quintiles, respectively, with evidence of linear trends across quintiles (P-trend = 0.0004-0.08). In flavonoid-rich food-based analyses, the HR was 0.82 (95% CI: 0.74, 0.91) among participants who consumed ≥2 servings citrus fruit or juices/d compared with <1 serving/wk. In the NHS only, total flavonoids, polymers, and proanthocyanidin intakes showed significantly (9-12%) lower depression risks. In analyses among late-life NHS participants (aged ≥65 y at baseline or during follow-up) higher intakes of all flavonoid subclasses except for flavan-3-ols were associated with significantly lower depression risk; flavones and proanthocyanidins showed the strongest associations (HR for both: 0.83; 95% CI: 0.77, 0.90). This study tested the hypotheses that, compared with placebo (an alkalized cocoa mixture containing essentially no epicatechin or procyanidins), the following beverages cause a decrease in appetite: 1) a nonalkalized cocoa mixture; 2) epicatechin plus placebo; and 3) procyanidins plus placebo. The concentrations of cocoa compounds were measured in all beverages. A 4-way randomized, crossover, placebo-controlled trial that was balanced for period and carryover effects was used in 28 healthy, young-adult men. A smaller (n = 14), parallel, secondary randomized trial was conducted in which the effects of higher doses of epicatechin and procyanidins were analyzed. The primary measure of appetite was ad libitum pizza intake 150 min after beverage ingestion. Intakes of beverages with the nonalkalized cocoa mixture that contained 0.6 mg epicatechin, 0.2 mg catechin, and 2.9 mg monomer-decamer procyanidins/kg body weight did not decrease pizza intake significantly compared with intake of the placebo. In the smaller secondary trial, a combination of epicatechin and the nonalkalized cocoa mixture that contained 1.6 mg epicatechin/kg body weight significantly decreased pizza intake by 18.7%.
Sleep Effects of Diet on Sleep Quality

Dietary Flavonoid Intake and Risk of Incident Depression in Midlife and Older Women
Sugar-Sweetened Beverages
Sugar-Sweetened Beverage Consumption and Genetic Predisposition to Obesity in 2 Swedish Cohorts BMI as the outcome. In an inverse variance-weighted fixed-effects meta-analysis, each SSB intake category increment was associated with a 0.18 higher BMI (SE=0.02; P=1.7 × 10 −20 ; n=26,726). In the fully adjusted model, a nominal significant interaction between SSB intake category and the unweighted GRS was observed (P-interaction=0.03). Comparing the participants within the top and bottom quartiles of the GRS to each increment in SSB intake was associated with 0.24 (SE=0.04; P=2.9 × 10 
